// App-Quantinova.ai

3818 : Reasons To Withhold Anticoagulation In Atrial Fibrillation Subjects After Ischemic Stroke

Researchers

Presenter

  • Jesse D Coull

Principal Investigators

  • Nadine Lendzion

  • Joyce Lee-Iannotti

  • Dan J Capampangan

  • Bart M Demaerschalk

  • David W Dodick

  • Timothy J Ingall

  • Bert B Vargas

  • Maria I Aguilar

Medical Centers

  • Mayo Clinic Arizona, Phoenix, AZ

  • Edmonton, AB, Canada

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Arrhythmia

  • Ischemic stroke

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Warfarin

Outcome

  • N/A


Study Design

  • superiority

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim